ATC code R03

ATC code R03 Drugs for obstructive airway diseases is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2]^[3] Subgroup R03 is part of the anatomical group R Respiratory system.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QR03.^[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

R03A Adrenergics, inhalants

R03AH Combinations of adrenergics

R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

R03AK01 Epinephrine and other drugs for obstructive airway diseases

R03AK02 Isoprenaline and other drugs for obstructive airway diseases

R03AK04 Salbutamol and sodium cromoglicate

R03AK05 Reproterol and sodium cromoglicate

R03AK06 Salmeterol and fluticasone

R03AK07 Formoterol and budesonide

R03AK08 Formoterol and beclometasone

R03AK09 Formoterol and mometasone

R03AK10 Vilanterol and fluticasone furoate

R03AK11 Formoterol and fluticasone

R03AK12 Salmeterol and budesonide

R03AK13 Salbutamol and beclometasone

R03AK14 Indacaterol and mometasone

R03AK15 Salbutamol and budesonide

R03AL Adrenergics in combinations with anticholinergics incl. triple combinations with corticosteroids

R03AL01 Fenoterol and ipratropium bromide

R03AL02 Salbutamol and ipratropium bromide

R03AL03 Vilanterol and umeclidinium bromide

R03AL04 Indacaterol and glycopyrronium bromide

R03AL05 Formoterol and aclidinium bromide

R03AL06 Olodaterol and tiotropium bromide

R03AL07 Formoterol and glycopyrronium bromide

R03AL08 Vilanterol, umeclidinium bromide, and fluticasone furoate

R03AL09 Formoterol, glycopyrronium bromide and beclometasone

R03AL10 Formoterol and tiotropium bromide

R03AL11 Formoterol, glycopyrronium bromide, and budesonide

R03AL12 Indacaterol, glycopyrronium bromide and mometasone

R03B Other drugs for obstructive airway diseases, inhalants

R03BA Glucocorticoids

R03BA01 Beclometasone

R03BA02 Budesonide

R03BA03 Flunisolide

R03BA04 Betamethasone

R03BA05 Fluticasone

R03BA06 Triamcinolone

R03BA07 Mometasone

R03BA08 Ciclesonide

R03BA09 Fluticasone furoate

R03BB Anticholinergics

R03BB01 Ipratropium bromide

R03BB02 Oxitropium bromide

R03BB03 Stramoni preparations

R03BB04 Tiotropium bromide

R03BB05 Aclidinium bromide

R03BB06 Glycopyrronium bromide

R03BB07 Umeclidinium bromide

R03BB08 Revefenacin

R03BB54 Tiotropium bromide, combinations

R03BC Antiallergic agents, excluding corticosteroids

R03BC01 Cromoglicic acid

R03BC03 Nedocromil

R03BX Other drugs for obstructive airway diseases, inhalants

R03BX01 Fenspiride

R03C Adrenergics for systemic use

R03CA Alpha- and beta-adrenoreceptor agonists

R03CA02 Ephedrine

R03CB Non-selective beta-adrenoreceptor agonists

R03CB01 Isoprenaline

R03CB02 Methoxyphenamine

R03CB03 Orciprenaline

R03CB51 Isoprenaline, combinations

R03CB53 Orciprenaline, combinations

R03CC Selective beta-2-adrenoreceptor agonists

R03CC02 Salbutamol

R03CC03 Terbutaline

R03CC04 Fenoterol

R03CC05 Hexoprenaline

R03CC06 Isoetarine

R03CC07 Pirbuterol

R03CC08 Procaterol

R03CC09 Tretoquinol

R03CC10 Carbuterol

R03CC11 Tulobuterol

R03CC12 Bambuterol

R03CC13 Clenbuterol

R03CC14 Reproterol

R03CC15 Formoterol

R03CC53 Terbutaline, combinations

R03CC63 Clenbuterol and ambroxol

QR03CC90 Clenbuterol, combinations

R03CK Adrenergics and other drugs for obstructive airway diseases

R03D Other systemic drugs for obstructive airway diseases

R03DA Xanthines

R03DA01 Diprophylline

R03DA02 Choline theophyllinate

R03DA03 Proxyphylline

R03DA04 Theophylline

R03DA05 Aminophylline

R03DA06 Etamiphylline

R03DA07 Theobromine

R03DA08 Bamifylline

R03DA09 Acefylline piperazine

R03DA10 Bufylline

R03DA11 Doxofylline

R03DA12 Mepyramine theophyllinacetate

R03DA20 Combinations of xanthines

R03DA51 Diprophylline, combinations

R03DA54 Theophylline, combinations excluding psycholeptics

R03DA55 Aminophylline, combinations

R03DA57 Theobromine, combinations

R03DA74 Theophylline, combinations with psycholeptics

R03DB Xanthines and adrenergics

R03DB01 Diprophylline and adrenergics

R03DB02 Choline theophyllinate and adrenergics

R03DB03 Proxyphylline and adrenergics

R03DB04 Theophylline and adrenergics

R03DB05 Aminophylline and adrenergics

R03DB06 Etamiphylline and adrenergics

R03DC Leukotriene receptor antagonists

R03DC01 Zafirlukast

R03DC02 Pranlukast

R03DC03 Montelukast

R03DC04 Ibudilast

R03DC53 Montelukast, combinations

R03DX Other systemic drugs for obstructive airway diseases

R03DX01 Amlexanox

R03DX02 Eprozinol

R03DX03 Fenspiride

R03DX05 Omalizumab

R03DX06 Seratrodast

R03DX07 Roflumilast

R03DX08 Reslizumab

R03DX09 Mepolizumab

R03DX10 Benralizumab

R03DX11 Tezepelumab

References

↑ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
↑ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
↑ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
↑ "ATC/DDD Index 2022: code R03". WHO Collaborating Centre for Drug Statistics Methodology.
↑ "ATCvet Index 2022: code QR03". WHO Collaborating Centre for Drug Statistics Methodology.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.

[2] World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.

[3] "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.

[4] "ATC/DDD Index 2022: code R03". WHO Collaborating Centre for Drug Statistics Methodology.

[5] "ATCvet Index 2022: code QR03". WHO Collaborating Centre for Drug Statistics Methodology.

[1]

[2]

[3]

[4]

[5]